Clinical Trials Logo

Clinical Trial Summary

An emergency laparotomy (EmLap) is a life-saving operationÍž but the aftermath for those that do survive can be lifechanging. Each year, in excess of 25,000 EmLaps are performed in UK. A national effort, through the National Emergency Laparotomy Audit (NELA), has managed to improve peri-operative care, and reduce 30 day mortality from 1 in 4 to less than 1 in 10. Whilst this reduction should be commended, it also means that more patients are surviving with some form of new infirmity. This infirmity may be short-lived and reversible in some, and yet others may transition into a permanent chronic disease state. The impact of EmLap on those individuals that "do not fully recover" is far-reaching and often interlinked, covering biological, social and psychological domains. This makes it difficult to describe the true problem, i.e. holistic morbidity and suggest an intervention to improve it. The primary aim of this work is to describe the holistic morbidity of EmLap throughout the first year of a patient's recovery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05281627
Study type Observational
Source Cardiff and Vale University Health Board
Contact
Status Active, not recruiting
Phase
Start date October 15, 2021
Completion date September 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04615520 - Evaluation of Surgical Risk Prediction Tools.
Recruiting NCT04878159 - Troponin T and Emergency High-risk Abdominal Surgery
Recruiting NCT04403425 - Tissue Perfusion During Emergency Laparotomy
Active, not recruiting NCT04311788 - Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial N/A